Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

NCT07014007 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
105
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pierre Fabre Dermo Cosmetique